Companies /Healthcare
Tango Therapeutics Inc
NASDAQ: TNGX Biotechnology
$22.04
▼ $0.66 (−2.91%) today
Markets closed · 2:35am ET

Tango Therapeutics (TNGX) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
33%
EPS beat rate
+46.20%
Avg. EPS surprise
Consecutive EPS misses
TNGX vs Market · 30-day return after each reportTNGXS&P 500
0%+90%+180%+270%+285.5%+3.6%Q1 25+0.4%+3.1%Q2 25+20.2%+1.6%Q3 25+17.7%−3.2%Q4 25+29.3%+0.3%Q1 26−9.7%−0.8%Q3 26
0%+90%+180%+270%Q1 25Q3 25Q1 26
TNGX EPS Trend · estimate vs actualEstimateActual
$-0.40$-0.20$0.00$-0.35$-0.36Q1 25$-0.34$-0.35Q2 25$-0.07$0.13Q3 25$-0.33$-0.29Q4 25$-0.31$-0.32Q1 26$-0.32$-0.37Q3 26
$-0.40$-0.20$0.00Q1 25Q3 25Q1 26
TNGX Revenue Trend · estimate vs actualEstimateActual
$0$20.0M$40.0M$6.7M$5.4MQ1 25$6.7M$3.2MQ2 25$41.2M$53.8MQ3 25
$0$20.0M$40.0MQ1 25Q2 25Q3 25

How Often Does Tango Therapeutics Beat Earnings Estimates?

Tango Therapeutics beat EPS estimates in 2 of its last 6 reported quarters, and has missed 2 quarters in a row.

TNGX quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 $-0.37 est. $-0.32 −14.23% — —
Q1 2026 $-0.32 est. $-0.31 −1.72% — —
Q4 2025 $-0.29 est. $-0.33 +11.83% — —
Q3 2025 $0.13 est. $-0.07 +287.32% $53.8M est. $41.2M +30.47%
Q2 2025 $-0.35 est. $-0.34 −1.92% $3.2M est. $6.7M −52.55%
Q1 2025 $-0.36 est. $-0.35 −4.08% $5.4M est. $6.7M −19.84%

Figures from SEC filings and company reports. Not investment advice.